UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Multistage Cooperative Nanoplatform Enables Intracellular Co‐Delivery of Proteins and Chemotherapeutics for Cancer Therapy

Advanced materials (Weinheim), 2020-11, Vol.32 (46), p.e2000013-n/a

2020

Volltextzugriff (PDF)

Co‐Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects

Advanced healthcare materials, 2018-01, Vol.7 (1), p.n/a

2018

Volltextzugriff (PDF)

Targeted Co‐delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer

Small (Weinheim an der Bergstrasse, Germany), 2017-01, Vol.13 (2), p.np-n/a

2017

Volltextzugriff (PDF)

Engineering of Cascade-Responsive Nanoplatform to Inhibit Lactate Efflux for Enhanced Tumor Chemo-Immunotherapy

ACS nano, 2020-10, Vol.14 (10), p.14164-14180

2020

Volltextzugriff (PDF)

Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy

Biomaterials, 2020-11, Vol.258, p.120275-120275, Article 120275

2020

Volltextzugriff (PDF)

Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma

Journal of controlled release, 2019-03, Vol.298, p.177-185

2019

Volltextzugriff (PDF)

Stimuli-sensitive nanopreparations for combination cancer therapy

Journal of controlled release, 2014-09, Vol.190, p.352-370

2014

Volltextzugriff (PDF)

Injectable and Self-Healing Thermosensitive Magnetic Hydrogel for Asynchronous Control Release of Doxorubicin and Docetaxel to Treat Triple-Negative Breast Cancer

ACS applied materials & interfaces, 2017-10, Vol.9 (39), p.33660-33673

2017

Volltextzugriff (PDF)

Nano-based delivery systems for berberine: A modern anti-cancer herbal medicine

Colloids and surfaces, B, Biointerfaces, 2020-10, Vol.194, p.111188, Article 111188

2020

Volltextzugriff (PDF)

Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy

Advanced healthcare materials, 2020-05, Vol.9 (10), p.e1901858-n/a

2020

Volltextzugriff (PDF)

Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles

Biomaterials, 2014-03, Vol.35 (10), p.3331-3339

2014

Volltextzugriff (PDF)

Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance

Nano today, 2012-08, Vol.7 (4), p.367-379

2012

Volltextzugriff (PDF)

Nanoparticle drug delivery systems for synergistic delivery of tumor therapy

Frontiers in pharmacology, 2023-02, Vol.14, p.1111991-1111991

2023

Volltextzugriff (PDF)

Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis

Journal of controlled release, 2020-05, Vol.321, p.463-474

2020

Volltextzugriff (PDF)

Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles

Environmental research, 2024-03, Vol.244, p.117264-117264, Article 117264

2024

Volltextzugriff (PDF)

Imatinib co-loaded targeted realgar nanocrystal for synergistic therapy of chronic myeloid leukemia

Journal of controlled release, 2021-10, Vol.338, p.190-200

2021

Volltextzugriff (PDF)

Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells

Colloids and surfaces, B, Biointerfaces, 2020-04, Vol.188, p.110762-110762, Article 110762

2020

Volltextzugriff (PDF)

Intracellular Co-delivery of native antibody and siRNA for combination therapy by using biodegradable silica nanocapsules

Biomaterials, 2022-02, Vol.281, p.121376-121376, Article 121376

2022

Volltextzugriff (PDF)

Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer

Expert opinion on drug delivery, 2017-02, Vol.14 (2), p.229-243

2017

Volltextzugriff (PDF)

Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy

Drug delivery, 2020-01, Vol.27 (1), p.1044-1053

2020

Volltextzugriff (PDF)

Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer

Biomaterials, 2014-05, Vol.35 (14), p.4333-4344

2014

Volltextzugriff (PDF)

Co-delivery of doxorubicin and hydroxychloroquine via chitosan/alginate nanoparticles for blocking autophagy and enhancing chemotherapy in breast cancer therapy

Frontiers in pharmacology, 2023-05, Vol.14, p.1176232-1176232

2023

Volltextzugriff (PDF)

Bioaccessibility of chlorogenic acid and curcumin co-encapsulated in double emulsions with the inner interface stabilized by functionalized silica nanoparticles

Food chemistry, 2024-07, Vol.445, p.138828-138828, Article 138828

2024

Volltextzugriff (PDF)

A modular ROS-responsive platform co-delivered by 10-hydroxycamptothecin and dexamethasone for cancer treatment

Journal of controlled release, 2021-12, Vol.340, p.102-113

2021

Volltextzugriff (PDF)

Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation

Life sciences (1973), 2020-09, Vol.256, p.117943, Article 117943

2020

Volltextzugriff (PDF)

1 – 25 von 264

Suche als RSS-Feed

Aktive Filter

ThemaNanoparticles

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(235)
Mit Volltextzugriff
(239)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(246)
Co-Delivery
(182)
Life Sciences & Biomedicine
(158)
Drug Delivery Systems
(136)
Humans
(119)
Pharmacology & Pharmacy
(101)
Animals
(89)
Cancer Therapies
(89)
Chemotherapy
(89)
Materials Science
(85)
Technology
(85)
Nanoscience & Nanotechnology
(84)
Science & Technology - Other Topics
(84)
Cancer
(74)
Drugs
(74)
Physical Sciences
(73)
Chemistry
(62)
Cell Line, Tumor
(57)
Materials Science, Biomaterials
(55)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Multistage Cooperative Nanoplatform Enables Intracellular Co‐Delivery of Proteins and Chemotherapeutics for Cancer Therapy

Co‐Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects

Targeted Co‐delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer

Engineering of Cascade-Responsive Nanoplatform to Inhibit Lactate Efflux for Enhanced Tumor Chemo-Immunotherapy

Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy

Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma

Stimuli-sensitive nanopreparations for combination cancer therapy

Injectable and Self-Healing Thermosensitive Magnetic Hydrogel for Asynchronous Control Release of Doxorubicin and Docetaxel to Treat Triple-Negative Breast Cancer

Nano-based delivery systems for berberine: A modern anti-cancer herbal medicine

Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy

Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles

Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance

Nanoparticle drug delivery systems for synergistic delivery of tumor therapy

Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis

Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles

Imatinib co-loaded targeted realgar nanocrystal for synergistic therapy of chronic myeloid leukemia

Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells

Intracellular Co-delivery of native antibody and siRNA for combination therapy by using biodegradable silica nanocapsules

Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer

Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy

Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer

Co-delivery of doxorubicin and hydroxychloroquine via chitosan/alginate nanoparticles for blocking autophagy and enhancing chemotherapy in breast cancer therapy

Bioaccessibility of chlorogenic acid and curcumin co-encapsulated in double emulsions with the inner interface stabilized by functionalized silica nanoparticles

A modular ROS-responsive platform co-delivered by 10-hydroxycamptothecin and dexamethasone for cancer treatment

Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation

Aktive Filter

Suchergebnisse filtern